DPP-IV inhibitors

Details for Australian Patent Application No. 2005251910 (hide)

Owner Santhera Pharmaceuticals (Schweiz) AG

Inventors Hill, Oliver; Hoffmann, Barbara; Thiemann, Meinolf; Cerezo-Galvez, Silvia; Matassa, Victor Giulio; Rosenbaum, Claudia; Edwards, Paul John; Nordhoff, Sonja; Rummey, Christian; Feurer, Achim

Agent Shelston IP

Pub. Number AU-A-2005251910

PCT Pub. Number WO2005/121089

Priority 04013511.3 08.06.04 EP

Filing date 8 June 2005

Wipo publication date 22 December 2005

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4465 (2006.01) - only substituted in position 4

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 211/26 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/121089 Priority application(s): WO2005/121089

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251911-DPP-IV inhibitors

2005251909-New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission